NDC 65219-828 – Otulfi
Ustekinumab 130 mg/26mL · Solution · Intravenous
Product NDC65219-828
Product details
- Brand name
- Otulfi
- Generic name
- Ustekinumab-aauz
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761379
- Marketed since
- February 22, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab 130 mg/26mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 65219-828-05 | 1 VIAL in 1 CARTON (65219-828-05) / 26 mL in 1 VIAL | Feb 22, 2024 |